Cross-laboratory replication of pseudomyxoma peritonei tumor microbiome reveals reproducible microbial signatures
Victoria F Nieciecki1,2, Faith C Blum3, Ryan C Johnson4
1Graduate Program in Cell & Molecular Biology, Colorado State University, Fort Collins, Colorado, USA.
Abstract:
Recent work has demonstrated that cancer-specific microbial communities often colonize tumor tissues. However, untangling low-biomass signals from environmental contamination makes this research technically challenging. We utilize pseudomyxoma peritonei (PMP), a cancer characterized by the spread of mucus-secreting cells throughout the peritoneal cavity, to develop a robust workflow for identifying reproducible tumor microbiomes. Typically originating from the rupture of an appendiceal tumor into the peritoneal cavity, metastasized tumors have been previously shown to harbor a core set of microbes. However, that work did not control for the potential contamination of these low microbial biomass samples. We expand upon these prior findings by characterizing the microbiome of 70 additional PMP tumors and six normal peritoneal control tissues along with appropriate laboratory controls. Additionally, DNA from a subset of 25 tissues was extracted and sequenced at an independent laboratory. We found evidence of reproducible microbial signatures between the replicates of six different PMP tumors that include a set of core taxa that may be introduced from surgical contamination, as well as patient-specific taxa that are also commonly implicated in colorectal cancer. In addition, preoperative chemotherapy treatment was found to reduce tumor microbiome diversity. Our findings demonstrate how independent sample replication can be a powerful approach to investigate low-biomass microbial communities associated with tumor tissues that will improve low microbial biomass research.IMPORTANCERecent work has demonstrated that microbial communities colonize over 30 different types of tumor tissues. The origin of these communities and their possible involvement in carcinogenesis or cancer treatment outcomes remains an unclear, yet important area of research. A current major challenge in characterizing low-biomass, tumor-associated microbiomes is the introduction of environmental contamination during collection, handling, DNA extraction, PCR, and sequencing. Here, we provide a framework for replicating low-biomass tumor microbiome samples to help identify tumors with robust microbial signals and low background contamination. Using this replication approach, we show that pseudomyxoma peritonei (PMP) tumors host reproducible microbial communities, including organisms that have previously been associated with colorectal cancer. Incorporating sample replication into future tumor microbiome studies is a promising approach that will help identify robust signals and increase reproducibility in the field.
Insights
This study developed a robust workflow to identify reproducible tumor microbiomes in low-biomass samples, like pseudomyxoma peritonei (PMP). Replication confirmed microbial signatures and identified patient-specific taxa, improving low microbial biomass research.
Area of Science:
- Microbiology
- Oncology
- Bioinformatics
Background:
- Cancer-specific microbial communities colonize tumor tissues, but low-biomass signals are challenging to distinguish from contamination.
- Pseudomyxoma peritonei (PMP) is a cancer characterized by widespread mucus-secreting cells, often originating from appendiceal tumors.
Purpose of the Study:
- To develop a robust workflow for identifying reproducible tumor microbiomes in low-biomass samples.
- To characterize the microbiome of PMP tumors and identify reproducible microbial signatures.
- To assess the impact of preoperative chemotherapy on tumor microbiome diversity.
Main Methods:
- Characterized the microbiome of 70 PMP tumors and six normal peritoneal tissues.
- Utilized laboratory and independent laboratory replication for DNA extraction and sequencing.
- Analyzed microbial signatures, including core and patient-specific taxa, and correlated with clinical data.
Main Results:
- Identified reproducible microbial signatures in PMP tumors, including core taxa potentially from surgical contamination and patient-specific taxa linked to colorectal cancer.
- Found that preoperative chemotherapy reduced tumor microbiome diversity.
- Demonstrated that sample replication is crucial for investigating low-biomass tumor-associated microbial communities.
Conclusions:
- A robust workflow using independent sample replication can identify reproducible microbial signatures in low-biomass tumor tissues.
- PMP tumors harbor reproducible microbial communities, with some taxa associated with colorectal cancer.
- Future tumor microbiome studies should incorporate replication to enhance signal detection and reproducibility.


